Magnetization transfer contrast (MTC) imaging has been used to study neuromelanin (NM) in Parkinson’s disease. By suppressing the background tissue using an MTC pulse in a T1W sequence, the NM becomes visible, supposedly because of its reduced T1. However, we show using STAGE (strategically acquired gradient echo) imaging with/without an MTC pulse that this is not the reason for its visibility. Rather, it is the increased water content relative to surrounding tissue that keeps the signal high. Using the appropriate choice of flip angles and resolution, the NM contrast on MTC images can be significantly increased.